PHASE 3, MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ZS-9: SUBGROUP ANALYSIS STRATIFIED BY BASELINE SERUM POTASSIUM LEVELS

被引：0
|
作者：
Singh, Bhupinder [1 ]
Rasmussen, Henrik S. [2 ]
Lavin, Phillip T. [3 ]
Yang, Alex [4 ]
Roger, Simon D. [5 ]
机构：
[1] Apex Res Riverside, Riverside, AZ USA
[2] ZS Pharma Inc, Coppell, TX USA
[3] Boston Biostat Res Fdn, Framingham, MA USA
[4] Xelay Acumen Inc, Belmont, CA USA
[5] Renal Res, Gosford, Australia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP321
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [31] Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
    Levin, B
    Thompson, JLP
    Levy, G
    Mitsumoto, H
    Kaufmann, P
    NEUROLOGY, 2006, 66 (11) : 1786 - 1786
  • [32] Cabergoline in advanced RLS: A double-blind, placebo-controlled, multicenter trial
    Stiasny-Kolster, K
    Ueberall, M
    Oertel, W
    MOVEMENT DISORDERS, 2002, 17 : S231 - S231
  • [33] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
    Meininger, V
    Asselain, B
    Guillet, P
    Leigh, PN
    Ludolph, A
    Lacomblez, L
    Robberecht, W
    NEUROLOGY, 2006, 66 (01) : 88 - 92
  • [34] A multicenter, double-blind, placebo-controlled trial of topiramate in essential tremor
    Jankovic, J
    Ondo, WG
    Stacy, MA
    Elble, RJ
    Pahwa, R
    Connor, GS
    Hulihan, JF
    Schwarzman, L
    Wu, SC
    MOVEMENT DISORDERS, 2004, 19 : S448 - S449
  • [35] A double-blind placebo-controlled randomised trial of pregabalin for alcohol dependence: interim analysis
    Krupitsky, E.
    Rybakova, K.
    Skurat, E.
    Kiselev, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S663 - S664
  • [36] The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial
    Wang, I-K.
    Wu, Y-Y.
    Yang, Y-F.
    Ting, I-W.
    Lin, C-C.
    Yen, T-H.
    Chen, J-H.
    Wang, C-H.
    Huang, C-C.
    Lin, H-C.
    BENEFICIAL MICROBES, 2015, 6 (04) : 423 - 430
  • [37] A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
    Lynch, David R.
    Perlman, Susan L.
    Meier, Thomas
    ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 941 - 947
  • [38] RAPID ONSET OF POTASSIUM: LOWERING WITH SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) ACROSS PATIENTS STRATIFIED BY RACE, AGE, AND COMORBIDITIES IN THE RANDOMIZED, DOUBLE: BLIND, PLACEBO: CONTROLLED PHASE 3 HARMONIZE STUDY
    Alpert, Joseph S.
    Singh, Bhupinder
    Menoyo, Jose
    Rasmussen, Henrik
    Kosiborod, Mikhail
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1345 - 1345
  • [39] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
    Wallace, Daniel J.
    Furie, Richard A.
    Tanaka, Yoshiya
    Kalunian, Kenneth C.
    Mosca, Marta
    Petri, Michelle A.
    Doerner, Thomas
    Cardiel, Mario H.
    Bruce, Ian N.
    Gomez, Elisa
    Carmack, Tara
    DeLozier, Amy M.
    Janes, Jonathan M.
    Linnik, Matthew D.
    de Bono, Stephanie
    Silk, Maria E.
    Hoffman, Robert W.
    LANCET, 2018, 392 (10143): : 222 - 231
  • [40] Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
    Kappos, Ludwig
    Hartung, Hans-Peter
    Freedman, Mark S.
    Boyko, Alexey
    Radue, Ernst Wilhelm
    Mikol, Daniel D.
    Lamarine, Marc
    Hyvert, Yann
    Freudensprung, Ulrich
    Plitz, Thomas
    van Beek, Johan
    LANCET NEUROLOGY, 2014, 13 (04): : 353 - 363
12345